Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome

NCT00424892 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibromyalgia

Interventions

DRUG: Desvenlafaxine Sustained Release

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer